Comparision of adition of Fentanyl and Ketamin to 5/1% lidocaine with paracervical block in reducing of post operative pain in curettage
Phase 2
- Conditions
- local anaesthesia.agents primarily acting on smooth and skeletal muscles and the respiratory system
- Registration Number
- IRCT201305204686N7
- Lead Sponsor
- Arak University of Medival Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
patient candidate curettage; age 20-45 years old; informed written consent for paracervical block.
Exclusion criteria: prolonged procedure >20 minutes; failure of block and need to general analgesia; allergy to analgesic substances occurring of any heart diseases.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: 30 and 60 minutes after intervention. Method of measurement: Clinical examination.
- Secondary Outcome Measures
Name Time Method Drug side effects. Timepoint: 30 and 60 minutes after intervention. Method of measurement: Clinical examination.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How do Fentanyl and Ketamine synergistically modulate opioid and NMDA receptors to enhance lidocaine's analgesic effect in IRCT201305204686N7?
What is the comparative efficacy of Fentanyl vs. Ketamine as adjuvants to 5/1% lidocaine for post-curettage pain management in IRCT201305204686N7?
Which biomarkers predict response to Fentanyl/Ketamine-lidocaine combinations in post-operative pain reduction (IRCT201305204686N7)?
What are the safety profiles and adverse event management strategies for Fentanyl and Ketamine in lidocaine paracervical blocks (IRCT201305204686N7)?
How do Fentanyl/Ketamine combinations compare to other local anesthetic adjuvants in post-curettage pain trials (IRCT201305204686N7)?